Progyny, Inc. Payments to Acquire Marketable Securities
Progyny, Inc. (PGNY) reported Payments to Acquire Marketable Securities of $90.48 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2021-11-08
- Progyny, Inc. payments to acquire marketable securities for the quarter ending 2021-09-30 was $7.00M, a 69.56% decline year-over-year.
- Progyny, Inc. payments to acquire marketable securities for the quarter ending 2021-06-30 was $21.34M.
- Progyny, Inc. payments to acquire marketable securities for the quarter ending 2021-03-31 was $62.15M.
- Progyny, Inc. payments to acquire marketable securities for the quarter ending 2020-12-31 was $38.99M.
- Progyny, Inc. payments to acquire marketable securities for fiscal 2020 was $103.96M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2021-09-30 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $28.34M derived: sum of 2 quarters · filed 2021-11-08 | $90.48M 10-Q · filed 2021-11-08 | $129.47M derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-06-30 | $21.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $83.48M 10-Q · filed 2021-08-06 | $122.47M derived: sum of 3 quarters · filed 2021-08-06 | $145.47M derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-03-31 | $62.15M 10-Q · filed 2021-05-07 | $101.13M derived: sum of 2 quarters · filed 2021-05-07 | $124.13M derived: sum of 3 quarters · filed 2021-11-08 | |
| 2020-12-31 | $38.99M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $61.98M derived: sum of 2 quarters · filed 2021-11-08 | $103.96M 10-K · filed 2021-03-01 | |
| 2020-09-30 | $23.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $64.98M 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | $41.98M 10-Q · filed 2021-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |